The patent covers methods, systems, compositions, and kits for the multiplexed detection of analytes in a sample.

The firm plans to use the proceeds to support its commercialization and R&D activities as well as for working capital and general corporate purposes.

Home testing firm LetsGetChecked announced on Tuesday that its ImPress lancing device has received 510(k) clearance from the US Food and Drug Administration for professional use. The single-use blood ...

According to the DOJ, a jury found that New York City-based Alexander Baldonado received tens of thousands of dollars in illegal cash kickbacks and bribes in exchange for ordering genetic cancer tests ...

Demand remains low, but lab stakeholders said the industry is significantly better prepared to meet a spike in H5N1 testing ...

NEW YORK – Drawing on its longstanding partnership with Becton Dickinson, Babson Diagnostics is aiming to further expand use of its US Food and Drug Administration-cleared blood collection system ...

Recent study results show that the single-target DNA methylation test performed with a negative predictive value of 97.6 percent.

The company was in violation of the stock exchange's requirements for the minimum bid price and the market value of listed securities.

NEW YORK – Roche Diagnostics announced Thursday that its Elecsys sFlt-1/PlGF ratio for preeclampsia has received 510(k) clearance from the US Food and Drug Administration. The prognostic test is ...